Jan Meeldijk
Impact in
- Molecular Biology top 5%
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Wnt/β-catenin signaling in development and cancer 4
- Cancer-related gene regulation 4
-
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3
- Co-authors
- Hans Clevers (5 shared papers)Olivier Destrée (1 shared paper)Mascha van Noort (1 shared paper)Ruurd van der Zee (1 shared paper)Elena Sancho (1 shared paper)Jennifer Robertson (1 shared paper)Gerwin Huls (1 shared paper)Eduard Batlle (1 shared paper)
- Journals
- mAbs (2 papers)Journal of Biological Chemistry (2 papers)European Journal of Immunology (2 papers)Clinical and Experimental Rheumatology (1 paper)Cell Death Discovery (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Jan Meeldijk
27 papers receiving 2.2k citations
Jan Meeldijk's Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 1.4k
- Oncology 481
- Microbiology 106
- Immunology 359
- Cellular and Molecular Neuroscience 296
Countries citing papers authored by Jan Meeldijk
This map shows the geographic impact of Jan Meeldijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Meeldijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Meeldijk more than expected).
Fields of papers citing papers by Jan Meeldijk
This network shows the impact of papers produced by Jan Meeldijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Meeldijk. The network helps show where Jan Meeldijk may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Meeldijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB Hit paper breakdown → | 2002 | 889 |
| 2 | 2002 | 419 | |
| 3 | 2000 | 277 | |
| 4 | 2001 | 160 | |
| 5 | 2003 | 83 | |
| 6 | 2021 | 45 | |
| 7 | 2015 | 43 | |
| 8 | 2014 | 34 | |
| 9 | 2014 | 29 | |
| 10 | 2000 | 28 | |
| 11 | 2016 | 26 | |
| 12 | 2017 | 24 | |
| 13 | 2018 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2017 | 18 | |
| 16 | 2023 | 16 | |
| 17 | 2016 | 15 | |
| 18 | 1989 | 14 | |
| 19 | 2011 | 14 | |
| 20 | 2020 | 9 |
About Jan Meeldijk
Jan Meeldijk is a scholar working on Molecular Biology, Immunology, Oncology, Epidemiology and Public Health, Environmental and Occupational Health, having authored 27 papers that have together received 2.2k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (4 papers), T-cell and B-cell Immunology (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer-related gene regulation (4 papers), Streptococcal Infections and Treatments (3 papers), Immune Cell Function and Interaction (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Oncology (481 citations), Microbiology (106 citations), Immunology (359 citations) and Cellular and Molecular Neuroscience (296 citations). Jan Meeldijk has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Hans Clevers, Olivier Destrée, Mascha van Noort, Ruurd van der Zee, Elena Sancho, Jennifer Robertson, Gerwin Huls, Eduard Batlle, Jeffrey T. Henderson and Marc van de Wetering. Their work appears in journals such as mAbs, Journal of Biological Chemistry, European Journal of Immunology, Clinical and Experimental Rheumatology and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.